✦ LIBER ✦

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

✍ Scribed by Brunsvig, P. F.; Kyte, J. A.; Kersten, C.; Sundstrom, S.; Moller, M.; Nyakas, M.; Hansen, G. L.; Gaudernack, G.; Aamdal, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II open label trial evaluating s

✍ Tim F Greten; Alejandro Forner; Firouzeh Korangy; Gisele N'Kontchou; Nathalie Ba 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 790 KB

215 A PHASE II OPEN LABEL TRIAL EVALUATI

✍ T.F. Greten; A. Forner; F. Korangy; G. N'Kontchou; N. Barget; C. Ayuso; L. Orman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Early results of a phase I clinical tria

✍ Steven Khoo; Catherine Storrer; Katie Harris; Yusuf Jama; Anna Smith; Zia Dehqan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Clinical and Immunologic Responses of HL

✍ Ritesh Patil; Guy T. Clifton; Jarrod P. Holmes; Asna Amin; Mark G. Carmichael; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 728 KB

Immunological monitoring of in vitro and

✍ S. Khoo; C.E. Storrer; K.A. Harris; Y.H. Jama; Z.A. Dehqanzada; C.D. Shriver; E. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Results of a phase I clinical trial of a

✍ Daniel P Gold; Richard A Smith; Anna B Golding; Elizabeth E Morgan; Tanya Dafash 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 199 KB